O intervenție unică asupra unei gene ar putea elimina colesterolul ridicat. Terapia genetică care ar putea înlocui pastilele

A unique gene intervention has shown promise in significantly reducing high cholesterol levels, potentially replacing traditional medications. A single infusion targeting the ANGPTL3 gene led to a 50% reduction in cholesterol over a year, with no major side effects reported. This experimental treatment, CTX310, utilizes CRISPR technology to induce a mutation in the liver, offering a long-lasting solution for patients with severe cholesterol issues. If further studies confirm these results, it could revolutionize treatment for young individuals with high cholesterol, reducing the need for daily medication.